Autoimmune diseases that stem from an autoaggression of the immune system toward a subject's own tissues and organs still represent a field of intense research in the hope to identify why this occurs ...
Scientists at the University of Illinois Chicago have turned an unlikely source into a potential new weapon against cancer: ...
A self-assembling peptide disrupts liver cancer lysosomes, helping lenvatinib and other therapies work better in mouse models without reformulating the drugs. (Nanowerk Spotlight) A potent cancer drug ...
This article is based on a poster originally authored by Ebru Aydin Kurtulmus, Dagmar Hildebrand, Fiordiligie Casilag, Verena Banschbach, Jessica Heckmann, Sarah Schott, Marc Botcherby and Volker ...
Response to Neoadjuvant Chemotherapy Combined With Regional Hyperthermia Predicts Long-Term Survival for Adult Patients With Retroperitoneal and Visceral High-Risk Soft Tissue Sarcomas ABSTRACT: ...
Cancer treatments often struggle with balancing efficacy and side effects. A new study scientists offers a promising solution using antibody-peptide inhibitor conjugates to target specific cell types ...
KAWASAKI, Japan--(BUSINESS WIRE)--PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company (President: Patrick C. Reid, hereinafter “PeptiDream”) (Tokyo:4587) today announced its ...
Protein detection and quantification are daily occurrences both in research and diagnostic laboratories. Also, follow-ups of therapeutic treatments and prognoses have grown to rely more and more on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results